Contemporary Issues
暂无分享,去创建一个
Daniel M. Hartung | Dennis N Bourdette | D. Bourdette | R. Whitham | Sharia M. Ahmed | Daniel M Hartung | Sharia M Ahmed | Ruth H Whitham
[1] H. Guirguis,et al. Strategies and impacts of new drug introduction: hemophilia treatment. , 2004, Journal of health care finance.
[2] Disciplinary Committee,et al. Royal Pharmaceutical Society of Great Britain , 2002 .
[3] J. Guo,et al. Price and Market-Share Competition of Anti-Ulcer Gastric Medications in the Ohio Medicaid Market , 2004, International Journal of Pharmaceutical Medicine.
[4] A. Relman,et al. America's other drug problem: how the drug industry distorts medicine and politics. , 2002, New republic.
[5] W. S. Comanor,et al. Strategic Pricing of New Pharmaceuticals , 1998, Review of Economics and Statistics.
[6] Myung-Soo Lee,et al. The Upward Spiral of Drug Costs: A Time Series Analysis of Drugs Used in the Treatment of Hemophilia , 2002, Thrombosis and Haemostasis.
[7] D. Goodin,et al. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis , 2003, Neurology.
[8] A K Wagner,et al. Segmented regression analysis of interrupted time series studies in medication use research , 2002, Journal of clinical pharmacy and therapeutics.